PGD2

Pgd2 is a lipid of Fatty Acyls (FA) class. Pgd2 is associated with abnormalities such as Inflammatory disorder, Pleurisy, Rhinitis, Dehydration and Pneumonia. The involved functions are known as antagonists, fat cell differentiation, Phosphorylation, Process and Gene Expression. Pgd2 often locates in Cell surface, Body tissue, Extracellular, Bone Marrow and Membrane. The associated genes with PGD2 are oxytocin, 1-desamino-(O-Et-Tyr)(2)-, P4HTM gene, PTGS2 gene, PTGDS gene and IL3 gene. The related lipids are 15-deoxyprostaglandin J2, Nonesterified Fatty Acids, Lipopolysaccharides, Steroids and Liposomes. The related experimental models are Knock-out and Rodent Model.

Cross Reference

Introduction

To understand associated biological information of PGD2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with PGD2?

PGD2 is suspected in Asthma, Dehydration, Allergic rhinitis NOS, Rhinitis, Infertility, Pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with PGD2

MeSH term MeSH ID Detail
Actinobacillus Infections D000189 4 associated lipids
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Anal Gland Neoplasms D000694 1 associated lipids
Anaphylaxis D000707 35 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Ascariasis D001196 3 associated lipids
Asthma D001249 52 associated lipids
Astrocytoma D001254 15 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Blister D001768 16 associated lipids
Blood Platelet Disorders D001791 12 associated lipids
Body Weight D001835 333 associated lipids
Brain Damage, Chronic D001925 6 associated lipids
Bronchial Spasm D001986 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Per page 10 20 50 100 | Total 189

PubChem Associated disorders and diseases

What pathways are associated with PGD2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with PGD2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with PGD2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with PGD2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with PGD2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with PGD2?

Knock-out

Knock-out are used in the study 'Multiple roles of the prostaglandin D2 signaling pathway in reproduction.' (Rossitto M et al., 2015).

Rodent Model

Rodent Model are used in the study 'PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.' (Kong D et al., 2016).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with PGD2

Download all related citations
Per page 10 20 50 100 | Total 3138
Authors Title Published Journal PubMed Link
Abdelrahman M et al. The peroxisome proliferator-activated receptor-gamma ligand 15-deoxyDelta12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock. 2004 Shock pmid:15545828
Chen F Endogenous inhibitors of nuclear factor-kappaB, an opportunity for cancer control. 2004 Cancer Res. pmid:15548674
Fogel-Petrovic M et al. Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2. 2004 Immunol. Cell Biol. pmid:14984594
Cheng S et al. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. 2004 J. Biol. Chem. pmid:15023995
Alvarez-Maqueda M et al. 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. 2004 J. Biol. Chem. pmid:15024026
Yuan Z et al. Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. 2004 J. Cardiovasc. Pharmacol. pmid:15167281
Dahlén SE and Kumlin M Monitoring mast cell activation by prostaglandin D2 in vivo. 2004 Thorax pmid:15170020
Bochenek G et al. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. 2004 Thorax pmid:15170023
Cheron A et al. 15-deoxy-Delta12,14-prostaglandin J2 inhibits glucocorticoid binding and signaling in macrophages through a peroxisome proliferator-activated receptor gamma-independent process. 2004 J. Immunol. pmid:15187150
Maddox JF et al. 15-deoxy prostaglandin J2 enhances allyl alcohol-induced toxicity in rat hepatocytes. 2004 Toxicol. Sci. pmid:14657518
Zhang X et al. Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells. 2004 Kidney Int. pmid:14871400
Ueta M et al. PPARgamma ligands attenuate mesangial contractile dysfunction in high glucose. 2004 Kidney Int. pmid:14871416
Badawi AF et al. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. 2004 Cancer Res. pmid:14871855
Reddy PS et al. The synthesis and effects of prostaglandins on the ovary of the crab Oziotelphusa senex senex. 2004 Gen. Comp. Endocrinol. pmid:14644642
Fernández-Tome M et al. p44/42(ERK1/2) MAPK and PLD activation by PGD2 preserves papillary phosphatidylcholine homeostasis. 2004 Biochem. Biophys. Res. Commun. pmid:15249196
Kanunfre CC et al. Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. 2004 Int. Immunopharmacol. pmid:15251113
Berry EB et al. Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells. 2004 Prostaglandins Leukot. Essent. Fatty Acids pmid:15253890
Collin M et al. Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. 2004 Crit. Care Med. pmid:15090969
Baolin L et al. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. 2004 Planta Med. pmid:15095144
Zang C et al. Peroxisome proliferator-activated receptor gamma ligands induce growth inhibition and apoptosis of human B lymphocytic leukemia. 2004 Leuk. Res. pmid:15109539
Jakob M et al. Chondrogenesis of expanded adult human articular chondrocytes is enhanced by specific prostaglandins. 2004 Rheumatology (Oxford) pmid:15113997
Verrier E et al. PPARgamma agonists ameliorate endothelial cell activation via inhibition of diacylglycerol-protein kinase C signaling pathway: role of diacylglycerol kinase. 2004 Circ. Res. pmid:15117825
Lappas M et al. Effect of nuclear factor-kappa B inhibitors and peroxisome proliferator-activated receptor-gamma ligands on PTHrP release from human fetal membranes. 2004 Sep-Oct Placenta pmid:15450387
Masuko-Hongo K [Role of prostaglandins in rheumatoid arthritis]. 2005 Nippon Rinsho pmid:15799333
Yuan J et al. Ligands for peroxisome proliferator-activated receptor gamma have potent antitumor effect against human renal cell carcinoma. 2005 Urology pmid:15780399
Kim S et al. Synthesis of 15R-PGD2: a potential DP2 receptor agonist. 2005 Bioorg. Med. Chem. Lett. pmid:15780624
Marshall JC Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? 2005 Intensive Care Med pmid:15782317
Gazi L et al. Delta12-prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes. 2005 Prostaglandins Other Lipid Mediat. pmid:15789622
Fowler CJ and Tiger G Cyclooxygenation of the arachidonoyl side chain of 1-arachidonoylglycerol and related compounds block their ability to prevent anandamide and 2-oleoylglycerol metabolism by rat brain in vitro. 2005 Biochem. Pharmacol. pmid:15794945
Dore-Duffy P et al. The CNS pericyte response to low oxygen: early synthesis of cyclopentenone prostaglandins of the J-series. 2005 Microvasc. Res. pmid:15797264
Liu J et al. Peroxisome proliferator activated receptor-gamma ligands induced cell growth inhibition and its influence on matrix metalloproteinase activity in human myeloid leukemia cells. 2005 Cancer Chemother. Pharmacol. pmid:15838654
Ji JD et al. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. 2005 Rheumatology (Oxford) pmid:15840591
Mitchell MD et al. Identification of 9alpha,11beta-prostaglandin F2 in human amniotic fluid and characterization of its production by human gestational tissues. 2005 J. Clin. Endocrinol. Metab. pmid:15840748
Usui S et al. Design, synthesis, and biological activity of novel PPARgamma ligands based on rosiglitazone and 15d-PGJ2. 2005 Bioorg. Med. Chem. Lett. pmid:15745794
Storer PD et al. Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. 2005 J. Neuroimmunol. pmid:15748950
Spik I et al. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. 2005 J. Immunol. pmid:15749909
Mochizuki M et al. Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury. 2005 Am. J. Respir. Crit. Care Med. pmid:15750045
Chou YH et al. The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. 2005 Int. J. Biochem. Cell Biol. pmid:15618017
Farrajota K et al. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. 2005 Arthritis Rheum. pmid:15641079
Liu JJ et al. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro. 2005 Ann. Oncol. pmid:15642706
Wu CC et al. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. 2005 Eur. J. Pharmacol. pmid:16313903
Son JK et al. Ginkgetin, a Biflavone from Ginko biloba leaves, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. 2005 Biol. Pharm. Bull. pmid:16327145
Nakajima N et al. [Alternation of ion transport of airway epithelium by eicosanoids]. 2005 Arerugi pmid:16407682
Coyle AT et al. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells. 2005 FEBS J. pmid:16156795
Chen WC et al. Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity. 2005 Chin. Med. J. pmid:16157051
Uehara Y [Prostaglandin D2]. 2005 Nippon Rinsho pmid:16149440
Zamuner SR et al. Predisposition to colorectal cancer in rats with resolved colitis: role of cyclooxygenase-2-derived prostaglandin d2. 2005 Am. J. Pathol. pmid:16251413
Negoro H et al. Endogenous prostaglandin D(2) synthesis decreases vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells. 2005 Life Sci. pmid:16154157
O'Flaherty JT et al. 5-Oxo-ETE analogs and the proliferation of cancer cells. 2005 Biochim. Biophys. Acta pmid:16154383
Schmidt R et al. LC-MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. 2005 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16172029
Iwata C et al. Augmentation of lipogenesis by 15-deoxy-Delta12,14-prostaglandin J2 in hamster sebaceous glands: identification of cytochrome P-450-mediated 15-deoxy-Delta12,14-prostaglandin J2 production. 2005 J. Invest. Dermatol. pmid:16297182
Thomas RK et al. Inhibition of nuclear translocation of nuclear factor-kappaB despite lack of functional IkappaBalpha protein overcomes multiple defects in apoptosis signaling in human B-cell malignancies. 2005 Clin. Cancer Res. pmid:16299251
Sugimoto M et al. Increased scratching counts depend on a decrease in ability of cutaneous prostaglandin D2 biosynthesis in NC/Nga mice with atopic dermatitis. 2005 Exp. Dermatol. pmid:16274457
Shiraki T et al. [Activation mechanism of PPARgamma by its endogenous ligands]. 2005 Tanpakushitsu Kakusan Koso pmid:16277244
Bianchi A et al. Contrasting effects of peroxisome-proliferator-activated receptor (PPAR)gamma agonists on membrane-associated prostaglandin E2 synthase-1 in IL-1beta-stimulated rat chondrocytes: evidence for PPARgamma-independent inhibition by 15-deoxy-Delta12,14prostaglandin J2. 2005 Arthritis Res. Ther. pmid:16277686
Shibata T and Uchida K [Current opinions on prostaglandin J2]. 2005 Seikagaku pmid:16241007
Shiraishi Y et al. Prostaglandin D2-induced eosinophilic airway inflammation is mediated by CRTH2 receptor. 2005 J. Pharmacol. Exp. Ther. pmid:15528449
Mouihate A et al. Fever suppression in near-term pregnant rats is dissociated from LPS-activated signaling pathways. 2005 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:16037126
Nakae K et al. Functional role of prostacyclin receptor in rat dorsal root ganglion neurons. 2005 Neurosci. Lett. pmid:16039053
Gelir E et al. Effect of rapid-eye-movement sleep deprivation on rat hypothalamic prostaglandins. 2005 Prostaglandins Leukot. Essent. Fatty Acids pmid:16039105
Masini E et al. Reduction of antigen-induced respiratory abnormalities and airway inflammation in sensitized guinea pigs by a superoxide dismutase mimetic. 2005 Free Radic. Biol. Med. pmid:16043023
Stahlschmidt J et al. Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease. 2005 Kidney Int. pmid:16105033
Appel S et al. PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. 2005 Blood pmid:16105976
Boyce JA Eicosanoid mediators of mast cells: receptors, regulation of synthesis, and pathobiologic implications. 2005 Chem Immunol Allergy pmid:16107763
Hata AN et al. Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2. 2005 J. Biol. Chem. pmid:16030019
Motilva V et al. COX expression and PGE(2) and PGD(2) production in experimental acute and chronic gastric lesions. 2005 Int. Immunopharmacol. pmid:15652766
Martínez B et al. The mitochondrial respiratory complex I is a target for 15-deoxy-delta12,14-prostaglandin J2 action. 2005 J. Lipid Res. pmid:15654126
Liang X et al. Prostaglandin D2 mediates neuronal protection via the DP1 receptor. 2005 J. Neurochem. pmid:15659218
Shen ZN et al. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21. 2005 Biochem. Biophys. Res. Commun. pmid:15694358
Shiraki T et al. Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma. 2005 J. Biol. Chem. pmid:15695504
Bulló M et al. Stimulation of NGF expression and secretion in 3T3-L1 adipocytes by prostaglandins PGD2, PGJ2, and Delta12-PGJ2. 2005 Am. J. Physiol. Endocrinol. Metab. pmid:15713689
García-Bueno B et al. The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. 2005 Psychopharmacology (Berl.) pmid:15719215
Malki S et al. Prostaglandin D2 induces nuclear import of the sex-determining factor SOX9 via its cAMP-PKA phosphorylation. 2005 EMBO J. pmid:15889150
Wang Z and Figueiredo-Pereira ME Inhibition of sequestosome 1/p62 up-regulation prevents aggregation of ubiquitinated proteins induced by prostaglandin J2 without reducing its neurotoxicity. 2005 Mol. Cell. Neurosci. pmid:15911346
Ishida A et al. Characterization of cAMP-dependent proteolysis of GATA-6. 2005 Biochem. Biophys. Res. Commun. pmid:15913546
Hennersdorf F et al. Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns in time kinetics of IgE-dependent upregulation. 2005 Cell Res. pmid:15916720
Hosoya T et al. Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. 2005 J. Biol. Chem. pmid:15917255
Andrews WJ et al. Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide production. 2005 J. Steroid Biochem. Mol. Biol. pmid:15862961
Allred CD and Kilgore MW Selective activation of PPARgamma in breast, colon, and lung cancer cell lines. 2005 Mol. Cell. Endocrinol. pmid:15866424
Marzocco S et al. The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. 2005 Intensive Care Med pmid:15868139
Yoshida M et al. Methotrexate suppresses inflammatory agonist induced interleukin 6 synthesis in osteoblasts. 2005 J. Rheumatol. pmid:15868610
Li X et al. Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes. 2005 J. Rheumatol. pmid:15868626
De Oliveira C et al. Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells. 2005 J. Lab. Clin. Med. pmid:15871306
Planagumà A et al. The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. 2005 FASEB J. pmid:15876570
Kim HY et al. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages. 2005 Immunol. Cell Biol. pmid:15877607
Blanco M et al. Increased plasma levels of 15-deoxyDelta prostaglandin J2 are associated with good outcome in acute atherothrombotic ischemic stroke. 2005 Stroke pmid:15879329
Hashimoto Y et al. Prostaglandin D2 inhibits IgE-mediated scratching by suppressing histamine release from mast cells. 2005 J. Pharmacol. Sci. pmid:15879676
Pataki I et al. In vivo effects of isatin on rat platelet eicosanoids. 2005 Platelets pmid:15763895
Martín AR et al. The COX-2 inhibitor, rofecoxib, ameliorates dextran sulphate sodium induced colitis in mice. 2005 Inflamm. Res. pmid:15883736
Chen YC et al. Prostaglandin D(2) and J(2) induce apoptosis in human leukemia cells via activation of the caspase 3 cascade and production of reactive oxygen species. 2005 Biochim. Biophys. Acta pmid:15843042
Gallant MA et al. Production of prostaglandin D(2) by human osteoblasts and modulation of osteoprotegerin, RANKL, and cellular migration by DP and CRTH2 receptors. 2005 J. Bone Miner. Res. pmid:15765187
Ibabe A et al. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. 2005 Toxicol In Vitro pmid:15964169
Pande V and Ramos MJ Molecular recognition of 15-deoxy-delta(12,14)-prostaglandin J2 by nuclear factor-kappa B and other cellular proteins. 2005 Bioorg. Med. Chem. Lett. pmid:16006125
Eggler AL et al. Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2. 2005 Proc. Natl. Acad. Sci. U.S.A. pmid:16006525
Matsuzaki Y et al. 15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. 2005 Int. J. Oncol. pmid:16010433
Kaplan JM et al. 15-Deoxy-delta(12,14)-prostaglandin J(2) (15D-PGJ(2)), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. 2005 Shock pmid:15988322
Tomita H et al. Troglitazone and 15-deoxy-delta(12,14)-prostaglandin J2 inhibit shear-induced coupling factor 6 release in endothelial cells. 2005 Cardiovasc. Res. pmid:15949477
Maurin AC et al. Expression of PPARgamma and beta/delta in human primary osteoblastic cells: influence of polyunsaturated fatty acids. 2005 Calcif. Tissue Int. pmid:15868283
Lindström TM and Bennett PR 15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. 2005 J. Clin. Endocrinol. Metab. pmid:15755849
Takashima T et al. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma. 2005 Oncol. Rep. pmid:15756430